Phase 2 Study of Two Potential CF Therapies VX-770 and VX-809 Shows Promising Results in Patients with Most Common Mutation
Originally posted in Cystic Fibrosis Foundation
No Comments »
RSS feed for comments on this post. TrackBack URL
Jun
09
2011
09
2011
by Raelene
